Pathway of Low Anterior Resection Syndrome Relief After Surgery: a Feasibility Study

NAUnknownINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Low Anterior Resection Syndrome
Interventions
DEVICE

Sacral NeuroModulation

Sacral Neuromodulation group will include up-to 20 patients with major LARS. Medtronic Interstim system will be used, including 2 week trial device.

DEVICE

Trans-Anal Irrigation

Trans-Anal irrigation group will include up-to 20 patients with major LARS. Specific system will be agreed with the patient, depending on eligibility and preference.

OTHER

Optimised Conservative Management

Optimised conservative management will include up-to 30 patients with major LARS. They will be provided with a resource booklet which includes dietary and lifestyle advice as well as exercises that can be undertaken independently.

Trial Locations (4)

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

LS9 7TF

Leeds Teaching Hospital NHS Trust, Leeds

CF14 4XW

Julie Cornish, Cardiff

NP20 2UB

Royal Gwent Hospital, Newport

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Leeds

OTHER

collaborator

Aneurin Bevan University Health Board

OTHER

collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

collaborator

Bowel Research UK

UNKNOWN

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

lead

Cardiff and Vale University Health Board

OTHER_GOV

NCT05319054 - Pathway of Low Anterior Resection Syndrome Relief After Surgery: a Feasibility Study | Biotech Hunter | Biotech Hunter